Fallopian Tube Cancers: Clinical Trials

3 trials for Fallopian Tube Cancers, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 1 recruiting. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Not yet recruiting 2, Recruiting 1
Phase 21Recruiting 1

Follow Fallopian Tube Cancers: new trials by email Literature Review of Fallopian Tube Cancers trials Research Report on Fallopian Tube Cancers

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Supplemental Arginine With Chemotherapy and Immunotherapy in Platinum Resistant Ovarian, Fallopian Tube, and Peritoneal Cancer
(ArginaidĀ®) Oral Arginine, (R-GeneĀ® 10) IV Arginine, Pembrolizumab - Platinum Resistant Ovarian Cancer, Fallopian Tube Cancers
Phase 1Not yet recruitingRebecca Arend242026-09-012026-10-15
IMMU-132 in TROP-2 Overexpressed Advanced and Relapsed Ovarian Cancer
Sacituzumab govitecan monotherapy - Epithelial Ovarian Cancer, Fallopian Tube Cancers
Phase 1Not yet recruitingShanghai Gynecologic Oncology Group192026-07-012026-06-30
CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer
TORL-1-23 and paclitaxel, TORL-1-23 and carboplatin, TORL-1-23, paclitaxel, and carboplatin - FIGO Stage III and IV Ovarian Cancer, Fallopian Tube Cancers
Phase 1 / Phase 2RecruitingTORL Biotherapeutics, LLC602025-12-102026-07-13

Narrower conditions

Fallopian Tube Neoplasms (3)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Ovarian Neoplasms (1)

Broader conditions

Adnexal Diseases (3)  ·  Fallopian Tube Diseases (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Genital Diseases (3)  ·  Genital Diseases, Female (3)  ·  Genital Neoplasms, Female (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Urogenital Diseases (3)  ·  Urogenital Neoplasms (3)  ·  Carcinoma (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Gonadal Disorders (1)

Interventions

Paclitaxel (2)  ·  Arginine (1)  ·  Bevacizumab (1)  ·  Carboplatin (1)  ·  Cyclophosphamide (1)  ·  Dimethoate (1)  ·  pembrolizumab (1)

Sponsors

Rebecca Arend (1)  ·  Shanghai Gynecologic Oncology Group (1)  ·  TORL Biotherapeutics, LLC (1)

Countries

United States (2)  ·  China (1)

Top investigators

Rebecca C Arend, MD (1)